Rapid progression of amyotrophic lateral sclerosis after initiation of GLP-1 agonist: a case report.
作者信息
Stolwyk Kathleen, Lee Ikjae
机构信息
Department of Clinical Nutrition, New York Presbyterian Hospital, New York, NY, USA and.
Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
出版信息
Amyotroph Lateral Scler Frontotemporal Degener. 2025 May;26(3-4):382-384. doi: 10.1080/21678421.2024.2446847. Epub 2025 Jan 7.
Abstract
摘要
相似文献
1
Rapid progression of amyotrophic lateral sclerosis after initiation of GLP-1 agonist: a case report.胰高血糖素样肽-1激动剂起始治疗后肌萎缩侧索硬化症的快速进展：一例报告
Amyotroph Lateral Scler Frontotemporal Degener. 2025 May;26(3-4):382-384. doi: 10.1080/21678421.2024.2446847. Epub 2025 Jan 7.
2
Skeletal muscle as a molecular and cellular biomarker of disease progression in amyotrophic lateral sclerosis: a narrative review.骨骼肌作为肌萎缩侧索硬化症疾病进展的分子和细胞生物标志物：一项叙述性综述
Neural Regen Res. 2024 Apr;19(4):747-753. doi: 10.4103/1673-5374.382226.
3
A patient with amyotrophic lateral sclerosis and atypical clinical and electrodiagnostic features: a case report.一名患有肌萎缩侧索硬化症且具有非典型临床和电诊断特征的患者：病例报告
J Med Case Rep. 2011 Nov 2;5:538. doi: 10.1186/1752-1947-5-538.
4
Case report: Flail leg syndrome in familial amyotrophic lateral sclerosis with L144S mutation.病例报告：伴有L144S突变的家族性肌萎缩侧索硬化中的连枷腿综合征
Front Neurol. 2023 Mar 22;14:1138668. doi: 10.3389/fneur.2023.1138668. eCollection 2023.
5
Pregnancy 5 Years After Onset of Amyotrophic Lateral Sclerosis Symptoms: A Case Report and Review of the Literature.肌萎缩侧索硬化症症状出现5年后怀孕：一例病例报告及文献综述
J Obstet Gynaecol Can. 2019 Jul;41(7):974-980. doi: 10.1016/j.jogc.2018.09.015. Epub 2018 Dec 7.
6
Illness trajectories in patients with amyotrophic lateral sclerosis: How illness progression is related to life narratives and interpersonal relationships.肌萎缩侧索硬化症患者的疾病轨迹：疾病进展与生活叙事和人际关系的关系。
J Clin Nurs. 2017 Dec;26(23-24):5033-5043. doi: 10.1111/jocn.14003. Epub 2017 Sep 29.
7
5'ValCAC tRNA fragment generated as part of a protective angiogenin response provides prognostic value in amyotrophic lateral sclerosis.作为保护性血管生成素反应一部分产生的5'ValCAC tRNA片段在肌萎缩侧索硬化症中具有预后价值。
Brain Commun. 2020 Aug 28;2(2):fcaa138. doi: 10.1093/braincomms/fcaa138. eCollection 2020.
8
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.肌肉组蛋白去乙酰化酶 4 在肌萎缩侧索硬化症中的上调：在重新支配能力和疾病进展中的潜在作用。
Brain. 2013 Aug;136(Pt 8):2359-68. doi: 10.1093/brain/awt164. Epub 2013 Jul 3.
9
A candidate protective factor in amyotrophic lateral sclerosis: heterogenous nuclear ribonucleoprotein G.肌萎缩侧索硬化症中的一个潜在保护因素：不均一核核糖核蛋白G
Neural Regen Res. 2023 Jul;18(7):1527-1534. doi: 10.4103/1673-5374.357916.
10
Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E angiogenin (ANG) mutation.肌萎缩侧索硬化症伴 p.K54E 血管生成素（ANG）突变缺乏独特的神经病理学特征。
Neuropathol Appl Neurobiol. 2013 Aug;39(5):562-71. doi: 10.1111/nan.12007.
本文引用的文献
1
Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies.基于胰高血糖素样肽-1 的治疗方法和缓解策略对去脂体重的影响。
Diabetes Obes Metab. 2024 Sep;26 Suppl 4:16-27. doi: 10.1111/dom.15728. Epub 2024 Jun 27.
2
Poll: Roughly 12% of US Adults Have Used a GLP-1 Drug, Even If Unaffordable.民意调查：约12%的美国成年人使用过胰高血糖素样肽-1（GLP-1）药物，即便负担不起。
JAMA. 2024 Jul 2;332(1):8. doi: 10.1001/jama.2024.10333.
3
Use of Continuous Glucose Monitoring and Glucagon-Like Peptide 1 Receptor Agonist Therapy to Achieve Individualized Treatment Goals in Insulin-Treated People With Type 2 Diabetes: A Case Series and Expert Opinion.使用持续葡萄糖监测和胰高血糖素样肽1受体激动剂疗法在胰岛素治疗的2型糖尿病患者中实现个体化治疗目标：病例系列与专家意见
Clin Diabetes. 2024 Spring;42(2):341-350. doi: 10.2337/cd23-0047. Epub 2023 Dec 5.
4
Higher Glycemic Index and Glycemic Load Diet Is Associated with Slower Disease Progression in Amyotrophic Lateral Sclerosis.高血糖指数和血糖负荷饮食与肌萎缩侧索硬化症的疾病进展缓慢有关。
Ann Neurol. 2024 Feb;95(2):217-229. doi: 10.1002/ana.26825. Epub 2023 Nov 29.
5
Body composition in amyotrophic lateral sclerosis subjects and its effect on disease progression and survival.肌萎缩侧索硬化症患者的身体成分及其对疾病进展和生存的影响。
Am J Clin Nutr. 2022 May 1;115(5):1378-1392. doi: 10.1093/ajcn/nqac016.
6
Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.脂肪量减少与肌萎缩侧索硬化症患者疾病进展更快相关：在一项前瞻性研究中探索双能 X 射线吸收法的实用性。
PLoS One. 2021 May 6;16(5):e0251087. doi: 10.1371/journal.pone.0251087. eCollection 2021.
7
Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort.肌萎缩侧索硬化症的早期体重减轻：基于人群队列的预后相关性和临床相关性。
J Neurol Neurosurg Psychiatry. 2019 Jun;90(6):666-673. doi: 10.1136/jnnp-2018-319611. Epub 2019 Jan 10.
8
Glucagon-like peptide 1 in health and disease.胰高血糖素样肽 1 在健康和疾病中的作用。
Nat Rev Endocrinol. 2018 Jul;14(7):390-403. doi: 10.1038/s41574-018-0016-2.
9
Prediagnostic body size and risk of amyotrophic lateral sclerosis death in 10 studies.10项研究中诊断前的身体大小与肌萎缩侧索硬化症死亡风险
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):396-406. doi: 10.1080/21678421.2018.1452944. Epub 2018 Apr 16.
10
Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans.体重指数与肌萎缩侧索硬化症：一项对美国退伍军人的研究。
Am J Epidemiol. 2017 Mar 1;185(5):362-371. doi: 10.1093/aje/kww140.
Zotero 插件